Skip to main content
Log in

Elucidation of Human Amphotericin B Pharmacokinetics: Identification of a New Potential Factor Affecting Interspecies Pharmacokinetic Scaling

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To elucidate the pharmacokinetics of amphotericin B in rats, mice and humans, and to perform interspecies scaling to humans using allometry.

Methods. Plasma concentrations following intravenous bolus administration in rats, and mice were determined by HPLC. Human pharmacokinetic parameters elucidated from literature data were validated in a preliminary study involving a patient receiving daily infusion dose for 27 days. A critical literature review was conducted to identify appropriate pharmacokinetic parameter values in other species for interspecies scale-up. Interspecies allometric scale-up was performed across mice, rats, rabbits and dogs and the resulting predictions in humans were compared to observed values.

Results. A triexponential decline in rat, mouse and human plasma concentrations were observed. No gender differences in rat pharmacokinetics were observed. In contrast to allometry, mouse CL was smaller (82 vs 116 ml/h/kg) and T0.5 (33 vs 20 h) was longer compared to rat. In the preliminary human study, Cpeak and Cmin values remained relatively constant over the duration of therapy, and a CL, MRT, T0.5, Vss and Vdarea of 26 ml/h/kg, 10 and 23 days, 6.2 and 20 L/kg, respectively, were estimated. The relative contributions of the terminal phase area in rat, mouse and human were 75%, 92% and 31%, respectively. Interspecies allometric scale-up predictions of human CL (41 ml/h/kg), CLu (467 ml/h/kg) and Vss (3.3 L/kg) were similar to reported values, whereas poor predictions of human Vuss (33 L/kg), Vdarea (4.1 L/kg) and T0.5 (3 days) were obtained.

Conclusions. Insignificant accumulation in humans inspite of the long terminal T0.5 was rationalized to be due to the small terminal-phase area contribution. While human CL and Vss were sucessfully predicted in the interspecies scaling, poor predictions of human Vdarea and T0.5 were obtained, which was attributed to disposition pattern differences between humans and other species, a potential new critical factor affecting interspecies scale-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. M. P. Nagata, C. A. Gentry, and E. M. Hampton. Is there a therapeutic or pharmacokinetic rationale for amphotericin B dosing in systemic candida infections? Annals Pharmacother. 30:811-818 (1996).

    Google Scholar 

  2. G. G. Chabot, R. Pazdur, F. A. Valeriote, and L. H. Baker. Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients. J. Pharm. Sci. 78:307-310 (1989).

    PubMed  Google Scholar 

  3. J. R. Starke, E. O. Mason, Jr., W. G. Kramer and S. L. Kaplan. Pharmacokinetics of amphotericin B in infants and children. J. Infect. Dis. 155:766-774 (1987).

    PubMed  Google Scholar 

  4. G. Koren, A. Lau, J. Klein, C. Golas, M. Bologa-Campeanu, S. Soldin, S. M. MacLeod, and C. Prober. Pharmacokinetics and adverse effects of amphotericin B in infants and children. J. Pediatr. 113:559-563 (1988).

    PubMed  Google Scholar 

  5. A. J. Atkinson, Jr., and J. E. Bennett. Amphotericin B pharmacokinetics in humans. Antimicrob. Agents Chemother. 13:271-276 (1978).

    PubMed  Google Scholar 

  6. H. H. Chow, Y. Wu, and M. Mayersohn. Pharmacokinetics of amphotericin B in rats as a function of dose following constant-rate intravenous infusion. Biopharm. Drug Disposit. 16:461-473 (1995).

    Google Scholar 

  7. L. H. Wang, R. M. Fielding, P. C. Smith, and L. S. S. Guo. Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil®) and Fungizone® after repeated dosing in rats. Pharm. Res. 12:275-283 (1995).

    PubMed  Google Scholar 

  8. H. H. Chow, Y. Cai, and M. Mayersohn. Disposition kinetics of amphotericin B in rats: the influence of dose. Drug Metab. Dispos. 20:432-435 (1992).

    PubMed  Google Scholar 

  9. R. M. Fielding, P. C. Smith, L. H. Wang, J. Porter, and L. S. S. Guo. Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats. Antimicrob. Agents Chemother. 35:1208-1213 (1991).

    PubMed  Google Scholar 

  10. K. Wasan, K. Vadiei, G. Lopez-Berestein, and D. R. Luke. Pharmacokinetics, tissue distribution and toxicity of free and liposomal amphotericin B in diabetic rats. J. Infect. Dis. 161:562-566 (1990).

    PubMed  Google Scholar 

  11. K. Vadiei, G. Lopez-Berestein, and D. R. Luke. Disposition and toxicity of amphotericin B in the hyperlipedimic zucker rat model. Int. J. Obesity 14:465-472 (1990).

    Google Scholar 

  12. H. Kim, D. Loebenberg, A. Marco, S. Symchowicz, and C. Lin. Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs and cynomolgus monkeys. Antimicrob. Agents Chemother. 26:446-449 (1984).

    PubMed  Google Scholar 

  13. J. A. Gondal, R. P. Swartz, and A. Rahman. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob. Agents Chemother. 33:1544-1548 (1989).

    PubMed  Google Scholar 

  14. J. W. Lee, M. A. Amantea. P. A. Francis, E. E. Navarro, J. Bacher, P. A. Pizzo, and T. J. Walsh. Pharmacokinetics and safety of a unilammelar liposomal formulation of amphotericin B (ambisome) in rabbits. Antimicrob. Agents Chemother. 38:713-718 (1994).

    PubMed  Google Scholar 

  15. L. C. Edmonds, L. Davidson, and J. S. Bertino. Effect of variation in infusion time and macrophage blockade on organ uptake of amphotericin B-deoxycholate. J. Antimicrob. Chemother. 28:919-924 (1991).

    PubMed  Google Scholar 

  16. P. C. Craven, T. M. Ludden, D. J. Drutz, W. Rogers, K. A. Haegele, and H. B. Skrdlant. Excretion pathways of amphotericin B. J. Infect. Dis. 140:329-341 (1979).

    PubMed  Google Scholar 

  17. F. A. Jagdis, P. D. Hoeprich, R. M. Lawrence, and C. P. Schaffner. Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macaca mulatta. Antimicrob. Agents Chemother. 12:582-590 (1977).

    PubMed  Google Scholar 

  18. A. Hutchaleelaha, H. H. Chow, and M. Mayersohn. Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species. J. Pharm. Pharmacol. 49:178-183 (1997).

    PubMed  Google Scholar 

  19. E. R. Block, J. E. Bennett, L. G. Livoti, W. J. Klein, R. R. MacGregor, and L. Henderson. Fluocytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Ann. Intern. Med. 80:613-617 (1974).

    PubMed  Google Scholar 

  20. W. L. Chiou, G. Robbie, S. M. Chung, T. C. Wu, and C. Ma. Relationship of plasma clearance of 54 extensively metabolized drugs between humans and rats: mean allometric coefficient of 0.66. Pharm. Res. (in press).

  21. C. L. Golas, C. G. Prober, S. M. MacLeod, and S. J. Soldin. Measurement of amphotericin B in serum or plasma by high-performance liquid chromatography. J. Chromatogr. 278:387-395, (1983).

    PubMed  Google Scholar 

  22. W. L. Chiou. Critical evaluation of the potential error in pharmacokinetic studies of using linear trapezoidal rule method for calculation of the area under the plasma level-time curve. J. Pharmacokin. Biopharm. 6:539-546 (1978).

    Google Scholar 

  23. W. L. Chiou, Compartment-and model-independent linear plateau principle of drugs during a constant-rate absorption or intravenous infusion. J. Pharmacokinet. Biopharm. 8:311-318 (1980).

    PubMed  Google Scholar 

  24. W. L. Chiou. New calculation method of mean total body clearance of drugs and its application to dosage regimens. J. Pharm. Sci. 69:90-91 (1980).

    PubMed  Google Scholar 

  25. W. L. Chiou. New calculation method for mean apparent drug volume of distribution and application to rational dosage regimens. J. Pharm. Sci. 68:1067-1069 (1979).

    PubMed  Google Scholar 

  26. H. Boxenbaum. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J. Pharmacokin. Biopharm. 10:201-227 (1982).

    Google Scholar 

  27. M. A. Gales and B. J. Gales. Rapid infusion of amphotericin B in dextrose. Annals Pharmacother. 29:523-529 (1995).

    Google Scholar 

  28. D. D. Bindschadler and J. E. Bennett. A Pharmacologic guide to the clinical use of amphotericin B. J. Infect. Dis. 120:427-436 (1969).

    PubMed  Google Scholar 

  29. D. J. Morgan, M. S. Ching, K. Raymond, R. W. Bury, L. Mashford, B. Kong, J. Sabto, W.Gurr, and A. A. Somogyi Elimination of amphotericin B in impaired renal function. Clin. Pharmacol. Ther. 34:248-253 (1983).

    PubMed  Google Scholar 

  30. J. M. Benson and M. C. Nahata. Pharmacokinetics of amphotericin B in children. Antimicrob. Agents Chemother. 33:1989-1993 (1989).

    PubMed  Google Scholar 

  31. M. Bouley, M. Todd, P. Chavanet, and O. Petitjean. The penetration of amphotericin B from an intralipid formulation into fibrin loci in a rabbit model of candidiasis. Biopharm. Drug Disposit. 15:485-492 (1994).

    Google Scholar 

  32. R. M. Fielding, A. W. Singer, L. H. Wang, S. Babbar, and L. S. S. Guo. Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs. Antimicrob. Agents Chemother. 36:299-307 (1992).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robbie, G., Chiou, W.L. Elucidation of Human Amphotericin B Pharmacokinetics: Identification of a New Potential Factor Affecting Interspecies Pharmacokinetic Scaling. Pharm Res 15, 1630–1636 (1998). https://doi.org/10.1023/A:1011923704731

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011923704731

Navigation